血小板增多

xuè xiǎo bǎn zēnɡ duō
  • thrombocytosis
血小板增多血小板增多
  1. 血小板增多多见,占53.3%。

    The percent of thrombocytosis is 53.3 % in all patients .

  2. 奥扎格雷钠干预治疗原发性血小板增多症合并血栓形成的研究

    Effects of Sodium Ozagrel in Primary Thrombocytosis Combined with Thrombosis

  3. 目的提高对bcr-abl融合基因阳性原发性血小板增多症(essentialthrombocythemia,ET)的认识。

    Objective To improve the recognition of bcr-abl gene positive essential thrombocythemia ( ET ) .

  4. bcr-abl融合基因阳性原发性血小板增多症一例报道并文献复习

    Bcr-abl gene positive essential thrombocythemia : one case report and literature review

  5. 病程中首次出现血小板增多的程度与骨转移的相关系数为0.336(p0.001)。

    The correlation coefficient between thrombocytosis and t bone metastasis is 0.336 ( p0.001 ) . 5 .

  6. 抗凋亡蛋白Bcl-xL在巨核细胞分化中的作用及其在原发性血小板增多症巨核细胞分化中表达的研究

    The Role of Antiapoptotic Bcl-x_L during Megakaryocyte Differentiation and in Essential Thrombocythemia

  7. 在NSCLC,血小板增多与骨转移有关:血小板增多的患者发生骨转移的比率增高。

    Thrombocytosis is correlated with bone metastasis in patients with NSCLC : the rate of bone metastasis is higher in patients with thrombocytosis than that in those without thrombocytosis . 5 .

  8. 慢性粒细胞白血病(CML)、真性红细胞增多症(PV)、原发性血小板增多症(ET)、慢性特发性骨髓纤维化(CIMF)均归于典型MPD;

    Classic MPDs comprise four subtypes : chronic myeloid leukemia ( CML ), polycythemia vera ( PV ), essential thrombocythemia ( ET ) and chronic idiopathic myelofibrosis ( CIMF ) .

  9. 血小板增多、VEGF表达与肿瘤大小、浸润深度、淋巴结转移、TNM分期、血管癌栓密切相关(P<0.01),血小板增多、VEGF阳性表达与胃癌预后呈负相关。

    The expression of VEGF and thrombocytosis were related to the tumour size , depth , lymph node metastasis , vessel invasion and TNM stage ( P < 0.01 ), The prognosis of patients with thrombocytosis and expression of VEGF was poor .

  10. 儿童原发性血小板增多症一例的研究Ⅱ超微结构观察

    A case of essential thrombocythemia in a child ⅱ ultrastructural observation

  11. 卵巢恶性肿瘤与血小板增多关系的临床研究

    Clinical studies on relation between ovarian malignant tumor and thrombocytosis

  12. 小儿原发性血小板增多症4例临床及实验室分析

    The clinical and laboratorial analysis of 4 pediatric patients with essential thrombocythemia

  13. 原发性血小板增多症血小板更新率与血栓形成的关系

    Correlation of Thrombosis with Increased Platelet Turnover in Essential Thrombocythemia

  14. 原发性血小板增多症发病机理与诊断治疗研究进展

    New Advances in Molecular Pathogenesis and Diagnosis of Essential Thrombocythemia

  15. 羟基脲加干扰素治疗原发性血小板增多症的临床疗效研究

    Clinical effectiveness of treatment with hydroxyurea plus interferon in patients with primary thrombocythemia

  16. 脾破裂术后血小板增多18例临床分析

    Clinical analysis of 18 cases with increased platelets after the operation for spleen rupture

  17. 原发性血小板增多症34例临床分析

    Clinical Analysis of 34 Cases With Essential Thrombocythemia

  18. 然而,原发性血小板增多症,尤其是有血栓风险时,需要接受治疗。

    However , in primary thrombocytosis , especially if there are other risk factors for thrombosis .

  19. 血小板增多、环氧化酶2在老年胃癌中表达及预后

    Poor prognosis associated with thrombocytosis and cyclooxygenase-2 ( COX-2 ) expression in aged patients with gastric carcinoma

  20. 本文报告了19例原发性血小板增多症的临床表现、实验室检查及治疗。

    The clinical appearance , laboratory examination and treatment in 19 cases of primary thrombocytosis are reported in this paper .

  21. 脾切除常可减轻患者的机械压迫症状,但脾切除的相关死亡率高,可加速肝大和极度的血小板增多。

    Splenectomy often relieve the symptoms of patients with mechanical pressure , but splenectomy related mortality is high , can accelerate liver and extreme thrombocytosis .

  22. 临床表现为脾脏肿大、外周血白细胞极度升高并出现幼稚粒细胞,嗜碱、嗜酸粒细胞增多,常有贫血、血小板增多。

    Clinical manifestations of CML include splenomegaly , extreme elevation of peripheral white blood cells , increasing of immature granulocyte macrophage , alkali , eosinophilia , anemia and thrombocytosis .

  23. 介绍了蝮蛇毒在冠心病、脑血管疾病、肺心病、皮肤病、糖尿病、原发性血小板增多症、周围血管疾病、肾病综合征等疾病中的临床应用。

    This paper presents the clinical application of venin in coronary heart disease , cerebral vascular disease , cor pulmonale dermatosis , diabetes mellitus , primary thrombocytosis , peripheral vascular disease , nephrotic syndrome etc.

  24. 结论DR患者存在血小板计数增多及活化增强带来的高凝状态,可能成为DR发生发展的一个重要因素。

    Conclusion DR patients have easily coagulated statue due to blood platelet count increasing and activation strengthening and it may be an important factor that makes DR occur and development .

  25. 骨髓抑制剂治疗脾切除后血小板异常增多的疗效分析

    Therapeutic effect of bone-marrow-inhibitor in the treatment of myelosis following splenectomy

  26. 血液分析仪对血小板异常增多白细胞计数失误分析

    Analysis of Mistake of W.B.C Count and Platelet Abnormal Incretion by Blood Analyzer

  27. 目的探讨血液分析仪对血小板异常增多患者的白细胞计数失误的关系。

    Objective To explore the relation of blood analyzer and mistake count of W.

  28. 慢性髓系白血病首发血小板显著增多

    Chronic Myeloid Leukemia Onset with Marked Thrombocythemia

  29. 同时抗CD59也促进补体诱导的血小板ATP分泌增多。

    Anti-CD59 enhanced platelet ATP release induces by CVF .

  30. 说明葛根素可降低因运动训练引起的血红蛋白的升高、红细胞数和血小板数的增多,降低血液的粘度,延长力竭游泳的时间,提高机体的运动能力。

    The puerarin may reduce the increase of hemoglobin , red blood cell and platelets caused by endurance exercise , reduce the blood viscosity , prolong the time of exhaustive swimming and improve exercise ability of mice in swim training .